These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34924308)

  • 21. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
    Yazaki S; Yoshida T; Kojima Y; Yagishita S; Nakahama H; Okinaka K; Matsushita H; Shiotsuka M; Kobayashi O; Iwata S; Narita Y; Ohba A; Takahashi M; Iwasa S; Kobayashi K; Ohe Y; Yoshida T; Hamada A; Doi T; Yamamoto N
    JAMA Oncol; 2021 Aug; 7(8):1141-1148. PubMed ID: 34047762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of six antibody assays and two combination assays for COVID-19.
    Yamamoto M; Okazaki K; Kitai Y; Shinohara K; Yukawa S; Noguchi T; Tanaka M; Matsumura Y; Nishiyama Y; Nagao M
    Virol J; 2022 Feb; 19(1):24. PubMed ID: 35115008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Sep; 5(5):908-920. PubMed ID: 32428207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of Cross-sectional and Longitudinal HLA and Anti-viral Responses After COVID Infection in Renal Allograft Recipients: Differences and Correlates.
    Girnita AL; Wang L; Colovai AI; Ahearn P; Azzi Y; Menon MC; Fernandez-Vina M; Gebel HM; Steve Woodle E; Cravedi P; Maltzman JS; Akalin E
    Transplantation; 2022 Oct; 106(10):2085-2091. PubMed ID: 36070571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical validation of a second generation anti-SARS-CoV-2 IgG and IgM automated chemiluminescent immunoassay.
    Pieri M; Nuccetelli M; Nicolai E; Sarubbi S; Grelli S; Bernardini S
    J Med Virol; 2021 Apr; 93(4):2523-2528. PubMed ID: 33463719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fcγ-Receptor-Based Enzyme-Linked Immunosorbent Assays for Sensitive, Specific, and Persistent Detection of Anti-SARS-CoV-2 Nucleocapsid Protein IgG Antibodies in Human Sera.
    Deschermeier C; Ehmen C; von Possel R; Murawski C; Rushton B; Amuasi J; Sarpong N; Maiga-Ascofaré O; Rakotozandrindrainy R; Asogun D; Ighodalo Y; Oestereich L; Duraffour S; Pahlmann M; Emmerich P
    J Clin Microbiol; 2022 Jun; 60(6):e0007522. PubMed ID: 35574677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan.
    Nakano Y; Kurano M; Morita Y; Shimura T; Yokoyama R; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    Sci Rep; 2021 Feb; 11(1):2776. PubMed ID: 33531605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal Comparison of Automated SARS-CoV-2 Serology Assays in Assessing Virus Neutralization Capacity in COVID-19 Convalescent Sera.
    Niedrist T; Drexler C; Torreiter PP; Matejka J; Strahlhofer-Augsten M; Kral S; Riegler S; Gülly C; Zurl C; Kriegl L; Krause R; Berghold A; Steinmetz I; Schlenke P; Herrmann M
    Arch Pathol Lab Med; 2022 May; 146(5):538-546. PubMed ID: 35085385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of 18 commercial serological assays for the detection of antibodies against SARS-CoV-2 in paired serum samples.
    Hanssen DAT; Slaats M; Mulder M; Savelkoul PHM; van Loo IHM
    Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1695-1703. PubMed ID: 33733395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Multiplex Microsphere IgG Assay for SARS-CoV-2 Using ACE2-Mediated Inhibition as a Surrogate for Neutralization.
    Cameron A; Porterfield CA; Byron LD; Wang J; Pearson Z; Bohrhunter JL; Cardillo AB; Ryan-Muntz L; Sorensen RA; Caserta MT; Angeloni S; Hardy DJ; Zand MS; Pecora ND
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.
    Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG
    Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A gold nanoparticles-based lateral flow assay utilizing baculovirus expressed recombinant nucleocapsid and receptor binding domain proteins for serodetection of IgG and IgM against SARS-CoV-2.
    Salem R; Elshamy AM; Kamel N; Younes S; Marie OM; Waly FR; El-Kholy AA; Elmenofy W
    Biotechnol Lett; 2022 Dec; 44(12):1507-1517. PubMed ID: 36319880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serological and viral genetic features of patients with COVID-19 in a selected German patient cohort-correlation with disease characteristics.
    Schmidt J; Berghaus S; Blessing F; Wenzel F; Herbeck H; Blessing J; Schierack P; Rödiger S; Roggenbuck D
    Geroscience; 2021 Oct; 43(5):2249-2264. PubMed ID: 34468954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analytical and Clinical Evaluation of the Semiquantitative Elecsys Anti-SARS-CoV-2 Spike Protein Receptor Binding Domain Antibody Assay on the Roche cobas e602 Analyzer.
    Chan CW; Yi X; Lenza M; Baldwin AD; Jakalski J; Tesic V; Yeo KJ
    Am J Clin Pathol; 2022 Jan; 157(1):109-118. PubMed ID: 34463315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Back to normal; serological testing for COVID-19 diagnosis unveils missed infections.
    Tsuchida T; Nitahara Y; Suzuki S; Komase Y; Candray K; Kido Y; Nakagama Y; Yamasaki Y; Imamura M; Kawahata K; Kunishima H; Fujitani S; Mineshita M; Matsuda T
    J Med Virol; 2021 Jul; 93(7):4549-4552. PubMed ID: 33739483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and clinical application of a rapid SARS-CoV-2 antibody test strip: A multi-center assessment across China.
    Liao M; Yan J; Wang X; Qian H; Wang C; Xu D; Wang B; Yang B; Liu S; Zhou M; Gao Q; Zhou Q; Luo J; Li Z; Liu W
    J Clin Lab Anal; 2021 Jan; 35(1):e23619. PubMed ID: 33067888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological Screening of Immunoglobulin G against SARS-CoV-2 Nucleocapsid and Spike Protein before and after Two Vaccine Doses among Healthcare Workers in Japan.
    Hiramoto S; Miyashita D; Kimura T; Niwa T; Uchida A; Sano M; Murata M; Nagasawa T; Tsunekawa K; Aoki T; Yoshida A; Kato T; Yanagisawa K; Tokue Y; Murakami M
    Tohoku J Exp Med; 2022 May; 257(1):57-64. PubMed ID: 35354694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.
    Isho B; Abe KT; Zuo M; Jamal AJ; Rathod B; Wang JH; Li Z; Chao G; Rojas OL; Bang YM; Pu A; Christie-Holmes N; Gervais C; Ceccarelli D; Samavarchi-Tehrani P; Guvenc F; Budylowski P; Li A; Paterson A; Yue FY; Marin LM; Caldwell L; Wrana JL; Colwill K; Sicheri F; Mubareka S; Gray-Owen SD; Drews SJ; Siqueira WL; Barrios-Rodiles M; Ostrowski M; Rini JM; Durocher Y; McGeer AJ; Gommerman JL; Gingras AC
    Sci Immunol; 2020 Oct; 5(52):. PubMed ID: 33033173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population.
    Ige F; Hamada Y; Steinhardt L; Iriemenam NC; Uwandu M; Greby SM; Aniedobe M; Salako BL; Rangaka MX; Abubakar I; Audu R
    Microbiol Spectr; 2021 Oct; 9(2):e0068021. PubMed ID: 34612691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.